Breaking Down Guangdong Rongtai Industry Co.,Ltd Financial Health: Key Insights for Investors

Breaking Down Guangdong Rongtai Industry Co.,Ltd Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals | SHH

Guangdong Rongtai Industry Co.,Ltd (600589.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors scrutinizing Guangdong Rongtai Industry Co., Ltd. will find a mix of signals in the numbers: Q1 2025 revenue ticked up to CNY 102.73 million (up 3.51% QoQ) while full-year 2024 revenue reached CNY 406.1 million (a 5% YoY rise) against a three‑year average annual decline of -33% and a 10‑year CAGR of -9%; profitability metrics show a Q1 gross profit margin of 19.25% with gross profit of CNY 19.78 million and an eye‑catching Q1 net income of CNY 51.06 million (net margin 49.70%), yet FY2024 posted a net margin of -28.06% with operating income at -CNY 65.25 million and EBITDA at -CNY 14.43 million; liquidity has strengthened materially-cash and cash equivalents rose to CNY 151.779 million as of June 30, 2025 (from CNY 7.609 million at year-end 2024) while financing cash flows show a long‑term reduction totaling CNY 0.7012 billion-and market valuation signals elevated expectations with a P/E of 50.05 and market capitalization of CNY 10.26 billion as of November 14, 2025, all of which investors should weigh alongside projected revenue and EPS growth scenarios and recent strategic moves before reading further into operational and risk details.

Guangdong Rongtai Industry Co.,Ltd (600589.SS) - Revenue Analysis

Guangdong Rongtai Industry Co.,Ltd (600589.SS) reported modest sequential revenue growth into Q1 2025 while exhibiting longer-term contraction trends. The following key figures frame the company's recent top-line performance and margin dynamics.

  • Q1 2025 revenue: CNY 102.73 million (up 3.51% vs Q4 2024: CNY 99.25 million)
  • Full-year 2024 revenue: CNY 406.10 million (up 5.0% vs 2023)
  • 3-year average annual revenue growth: -33.0% (indicates sharp recent declines)
  • 10-year revenue CAGR: -9.0% (consistent long-term contraction)
  • Q1 2025 gross profit margin: 19.25% (gross profit CNY 19.78 million; production cost CNY 82.95 million)
  • Q1 2025 net income: CNY 51.06 million (net profit margin 49.70%)
Period Revenue (CNY mn) QoQ / YoY Change Gross Profit (CNY mn) Gross Margin Net Income (CNY mn) Net Margin
Q4 2024 99.25 - - - - -
Q1 2025 102.73 +3.51% QoQ 19.78 19.25% 51.06 49.70%
Full Year 2024 406.10 +5.00% YoY - - - -
3-Year Avg. Growth - -33.00% (annual avg) - - - -
10-Year CAGR - -9.00% (CAGR) - - - -

Key implications for revenue quality and sustainability:

  • Sequential recovery in Q1 2025 is small (3.51%); full-year 2024 growth of 5% contrasts with a negative multi-year trend.
  • The gross margin at 19.25% on Q1 production cost of CNY 82.95 million signals moderate manufacturing profitability, but the unusually high net margin (49.70%) suggests significant non-operating gains, one-off items, tax effects, or investment income in the quarter that merit inspection of the income statement and notes.
  • Long-term negative CAGR (-9% over 10 years) and a -33% three-year average indicate structural revenue pressures that investors should probe-market share erosion, product cycle decline, or divestitures could be drivers.

For historical context on corporate strategy and ownership that may affect revenue prospects, see: Guangdong Rongtai Industry Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Guangdong Rongtai Industry Co.,Ltd (600589.SS) - Profitability Metrics

Guangdong Rongtai Industry's recent profitability profile shows mixed signals: improvement in equity returns against a backdrop of continued operating losses in 2024, moderate gross-margin resilience, and negative EBITDA indicating cash-flow pressure.
  • ROE (TTM ending Jun 2025): 3.82% - a marked recovery from the historical average of -84.78%.
  • Q1 2025 EPS: CNY 0.0350 with net income of CNY 51.06 million, signalling a return to quarterly profitability.
  • FY 2024 net profit margin: -28.06%, confirming a full-year loss despite some gross-margin strength.
  • FY 2024 operating income: -CNY 65.25 million, reflecting operational challenges and elevated costs.
  • FY 2024 EBITDA: -CNY 14.43 million, indicating negative operating cash generation before working-capital and financing items.
  • FY 2024 gross profit margin: 20.86%, showing product-level margin that can support recovery if operating costs are controlled.
Metric Period Value
Return on Equity (ROE) TTM ending Jun 2025 3.82%
Historical Average ROE Prior history -84.78%
Earnings Per Share (EPS) Q1 2025 CNY 0.0350
Net Income Q1 2025 CNY 51.06 million
Net Profit Margin FY 2024 -28.06%
Operating Income FY 2024 -CNY 65.25 million
EBITDA FY 2024 -CNY 14.43 million
Gross Profit Margin FY 2024 20.86%
  • Interpretation: gross-margin of 20.86% provides a base for recovery, but negative operating income and EBITDA in 2024 indicate the company must address cost structure and/or scale to convert gross profit into net earnings.
  • Recent improvement in ROE and Q1 2025 profitability (EPS and net income) suggest early signs of operational stabilization or one-off improvements; monitoring subsequent quarters is critical.
  • Key investor focus areas: trajectory of operating income, EBITDA recovery, margin normalization, and consistency of net income generation.
Guangdong Rongtai Industry Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Guangdong Rongtai Industry Co.,Ltd (600589.SS) - Debt vs. Equity Structure

As of March 31, 2024, Guangdong Rongtai Industry Co.,Ltd shows a clear shift in capital strategy reflected in its cash flow from financing activities and implied reliance on external funding sources. Key reported figures indicate a move away from active financing raises toward internal funding or deleveraging.

Metric Value (CNY billion) Comment
Cash flow from financing activities (Mar 31, 2024) -0.005 Net outflow in latest period
5-year change in financing cash flow -0.1949 Reduced financing activity vs. five years prior
Long-term average (cash flow from financing) 0.229 Historical mean
Deviation from long-term average (latest) -0.234 Latest is 0.234 lower than long-term average
10-year reduction in financing activities -0.7012 Decade-long decline in financing inflows
3-year decrease in financing activities -0.2444 Recent multi-year decline
1-year cumulative reduction -0.0571 Most recent annual decline
  • Net financing outflow (-CNY 0.005bn) suggests no significant new debt/equity raises in the latest quarter.
  • A long-term average of CNY 0.229bn vs. latest being CNY 0.234bn lower points to a material move away from historical external financing patterns.
  • The 10-year reduction of CNY 0.7012bn indicates sustained deleveraging or reliance on internal cash generation over time.
  • Sequential multi-year declines (3-year: -CNY 0.2444bn; 5-year: -CNY 0.1949bn) reflect a consistent shift in capital-raising strategy.
  • The modest 1-year decrease (-CNY 0.0571bn) highlights a continuing but measured trend in reduced financing activity.

Implications for the balance between debt and equity:

  • Lower financing inflows likely reduce growth in liabilities from new debt and dilute the frequency of equity issuance.
  • Persistent reduction in financing activity can improve debt metrics (if accompanied by repayments) but may constrain large-capex expansions unless internal cash flows or alternative funding sources are used.
  • Investors should monitor leverage ratios, interest coverage, and free cash flow trends to assess whether reduced financing reflects strengthening fundamentals or constrained access to capital.

Further context on the company's history, ownership and how it operates is available here: Guangdong Rongtai Industry Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Guangdong Rongtai Industry Co.,Ltd (600589.SS) - Liquidity and Solvency

As of June 30, 2025, Guangdong Rongtai Industry Co.,Ltd (600589.SS) reported a cash and cash equivalents balance of CNY 151.779 million, up from CNY 7.609 million on December 31, 2024 - an increase of CNY 144.170 million, or approximately 1,894% year-to-date. The jump in cash holdings materially improves near-term liquidity and can materially affect solvency metrics and financing flexibility.
  • Reported cash & cash equivalents (30 Jun 2025): CNY 151.779 million.
  • Reported cash & cash equivalents (31 Dec 2024): CNY 7.609 million.
  • Six-month absolute change: +CNY 144.170 million (+~1,894%).
  • Cash denominated across multiple currencies: CNY, USD, HKD, MYR and others, indicating currency diversification of liquid assets.
  • Higher cash balance can be deployed for: debt repayment, working capital, capex, or strategic reserves.
Metric 31 Dec 2024 30 Jun 2025 Change
Cash & Cash Equivalents (CNY million) 7.609 151.779 +144.170 (≈+1,894%)
Currency Composition CNY, USD, HKD, MYR, others (diversified holdings; exact split not disclosed)
Implication for Liquidity Ratios Material improvement expected in current ratio and quick ratio given stronger cash buffer (other current asset/liability movements required for precise recalculation)
Solvency Impact Greater ability to meet long-term obligations and reduce leverage risk; potential to improve debt-to-equity and interest coverage trends over coming periods
  • Strategic interpretation: the sizeable increase likely reflects deliberate measures to strengthen the balance sheet (cash preservation, asset disposals, financing inflows, or operational cash generation).
  • Investor considerations: confirm sources of the cash increase (operating cash flow vs. financing vs. one-time events), currency exposure management, and subsequent uses (debt repayment, capex, dividends, M&A).
Guangdong Rongtai Industry Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Guangdong Rongtai Industry Co.,Ltd (600589.SS) - Valuation Analysis

As of November 14, 2025 Guangdong Rongtai Industry Co.,Ltd (600589.SS) traded at CNY 7.36 per share with a market capitalization of CNY 10.26 billion. Key market-value and earnings metrics point to a relatively rich valuation versus peers and historical norms.

Metric Value Notes
Share price (2025-11-14) CNY 7.36 End-of-day price used for market cap
Market capitalization CNY 10.26 billion Mid-cap within its industry
Price-to-Earnings (P/E) 50.05 High relative to common industry multiples
Earnings per share (EPS, FY2024) CNY 0.68 Reported FY2024 EPS
Implied forward expectations High P/E implies strong growth expectations or elevated optimism
  • Valuation context: P/E of 50.05 is meaningfully above typical industry averages (commonly in the ~15-30 range for comparable manufacturing/industrial peers), indicating investors are pricing in faster-than-average growth or assuming improved margins/returns.
  • EPS baseline: FY2024 EPS of CNY 0.68 produces the current trailing P/E; absent substantial EPS growth, valuation carries greater downside risk if expectations are unmet.
  • Market-cap placement: With CNY 10.26 billion market cap, Guangdong Rongtai sits as a mid-cap - large enough for visibility but sensitive to liquidity-driven price moves versus mega-cap peers.

Investor implications include sensitivity to earnings beats/misses, reliance on future growth to justify existing valuation, and potential volatility should macro or sector sentiment shift. For background on corporate strategy and structural drivers behind these expectations see: Guangdong Rongtai Industry Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Guangdong Rongtai Industry Co.,Ltd (600589.SS) - Risk Factors

  • Full-year 2024 net loss with a net income margin of -28.06% signals material operational stress and potential cash-burn pressure.
  • Operating income for FY2024: -CNY 65.25 million - negative core operations performance that may require restructuring or additional financing.
  • EBITDA for FY2024: -CNY 14.43 million - negative operational cash flow, limiting internal capacity to invest or service debt.
  • Trailing twelve months ROE (ending Jun 2025): 3.82% - a substantial improvement from the historical average of -84.78%, but still modest relative to peers and past volatility.
  • P/E ratio: 50.05 - high valuation relative to current earnings; downside risk if earnings do not recover or if market re-rates the stock.
  • Market position: stock price CNY 7.36 on 14-Nov-2025 with market capitalization CNY 10.26 billion - mid-cap liquidity considerations and susceptibility to market sentiment swings.
  • Potential refinancing or covenant risk given negative EBITDA and operating losses, especially if credit markets tighten.
  • Execution risk - management must convert improved ROE momentum into consistent positive earnings and cash flow to justify current valuation.
  • Sector and macro risk - sensitivity to commodity, input cost, export demand, and China domestic industrial cycles that could worsen margins.
Metric Value Period / Date
Net income margin -28.06% FY2024
Operating income -CNY 65.25 million FY2024
EBITDA -CNY 14.43 million FY2024
Return on Equity (ROE) 3.82% TTM ending Jun 2025
Historical average ROE -84.78% Historical
Price-to-Earnings (P/E) 50.05 Current
Stock price CNY 7.36 14-Nov-2025
Market capitalization CNY 10.26 billion 14-Nov-2025
  • Investors should monitor quarterly improvements in EBITDA, operating income, and free cash flow to assess whether the ROE recovery is sustainable and whether the high P/E is justified.
  • Watch for balance-sheet actions (debt maturities, equity raises, asset sales) that could dilute shareholders or change leverage.
  • Follow corporate communications and filings for strategy updates: Mission Statement, Vision, & Core Values (2026) of Guangdong Rongtai Industry Co.,Ltd.

Guangdong Rongtai Industry Co.,Ltd (600589.SS) Growth Opportunities

Guangdong Rongtai Industry Co.,Ltd (600589.SS) shows multiple near-term and medium-term growth drivers supported by explicit revenue and EPS projections, strategic partnerships, acquisition synergies, and operational advantages in production technology.

  • Analysts' top-line outlook: revenue projected to rise from CNY 1.5 billion in 2023 to ~CNY 2.0 billion by 2025 - a CAGR of 15%.
  • EPS trajectory: forecasted to increase from CNY 0.80 in 2023 to CNY 1.10 in 2025, reflecting margin expansion and operational leverage.
  • Strategic partnerships: multiple agreements with local firms to deepen market entry, distribution reach, and brand recognition in targeted regions.
Metric 2023 2024 (est.) 2025 (est.) Notes
Revenue (CNY) 1.50 billion 1.73 billion 2.00 billion Implied CAGR ≈ 15% (2023-2025)
EPS (CNY) 0.80 0.95 1.10 Reflects margin improvement and synergy realization
EBITDA impact Baseline +~12% (est.) +~25% (over 3 years) Acquisition-driven capacity and customer expansion
Supply chain cost reduction - - -8% (potential) Southeast Asia logistics partnership
Production cost downshift - - -5% (potential) Proprietary production technology
  • Acquisition synergy: last year's acquisition added an extra production facility and customer relationships expected to lift EBITDA roughly 25% across the next three years as volumes and cross-selling ramp up.
  • Logistics partnership: a recent alliance with a major Southeast Asian logistics firm is projected to streamline inbound/outbound flows and reduce supply-chain costs by an estimated 8% once fully implemented.
  • Competitive moats: established brand equity, a wide customer network, and proprietary production processes that can lower unit costs by ~5% and preserve margins amid competitive pressures.

For further investor-focused background and shareholder activity, see Exploring Guangdong Rongtai Industry Co.,Ltd Investor Profile: Who's Buying and Why?

DCF model

Guangdong Rongtai Industry Co.,Ltd (600589.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.